0 Ask Beta Account

Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies

Roberto Angioli, Matteo Bertelli, Natale Capodicasa, Marco Castori, Pietro Chiurazzi, Leonardo D'Agruma, Kalantary Rad Farshid, Ezio Fulcheri, Aysha Karim Kiani, Sandro Michelini, Angelantonio Notarangelo, Stefano Paolacci, Paolo Petralia, Daniela Piccinelli, Francesco Plotti, Pietro Scanzano, Corrado Terranova, Gerolamo Tonini

  • Department of Obstetrics and Gynecology, University Campus Bio Medico, Rome, Italy. R.Angioli@unicampus.it.
  • MAGI EUREGIO, Bolzano, Italy; MAGI'S LAB, Rovereto (TN), Italy; EBTNA-LAB, Rovereto (TN), Italy. matteo.bertelli@assomagi.org.
  • Magi Balkans - Rare Genetic Diseases, Tirana, Albania. ncapodicasa@yahoo.it.
  • Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy. m.castori@operapadrepio.it.
  • Istituto di Medicina Genomica, Università Cattolica del Sacro Cuore, Rome, Italy; UOC Genetica Medica, Fondazione Policlinico Universitario A. Gemelli, Rome Italy. pietrosmile@yahoo.com.
  • Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy. l.dagruma@operapadrepio.it.
  • Surgical Department, Unit of Urology, Poliambulanza Foundation, Brescia, Italy. farshid.kalantaryrad@poliambulanza.it.
  • UOSD Fetal and Perinatal Pathology, Department of Translational Research, Laboratory Medicine, Diagnostics and Services, IRCCS Giannina Gaslini Institute, Genoa, Italy. eziofulcheri@gaslini.org.
  • MAGI EUREGIO, Bolzano, Italy. ayshakiani@gmail.com.
  • Department of Vascular Rehabilitation, San Giovanni Battista Hospital, Rome, Italy. s.michelini@acismom.it.
  • Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy. a.notarangelo@operapadrepio.it.
  • MAGI'S LAB. stefano.paolacci@assomagi.org.
  • General Director, IRCCS Giannina Gaslini Institute, Genoa, Italy. paolopetralia@gaslini.org.
  • Department of Mother and Child Health, Unit of Obstetrics and Gynecology, Poliambulanza Foundation, Brescia, Italy. daniela.piccinelli@poliambulanza.it.
  • Department of Obstetrics and Gynecology, University Campus Bio Medico, Rome, Italy. f.plotti@unicampus.it.
  • Director, San Giovanni Battista Hospital, Rome, Italy. p.scanzano@acismom.it.
  • Department of Obstetrics and Gynecology, University Campus Bio Medico, Rome, Italy. C.Terranova@unicampus.it.
  • Surgical Department, Unit of Urology, Poliambulanza Foundation, Brescia, Italy. gerolamotonini@libero.it.

Acta Bio-medica : Atenei Parmensis, 91(13-S), e2020018

DOI 10.23750/abm.v91i13-S.10525 PMID 33170179

Abstract

BACKGROUND AND

Aim

Infertility affects ~20% of the couples in the world. Assisted reproductive technologies (ARTs) are currently the most common treatment option for infertility. Nevertheless, ARTs may be associated with complications for mothers and/or offspring. Natural procreative technology (NaProTechnology) is a natural treatment which minimizes these risks by seeking to identify the causes of infertility to enable better treatments. This narrative review summarizes the complications related to ARTs and clarifies how the NaProTechnology approach can help ARTs to achieve better results or be used in alternative to ARTs.

Methods

Data in the literature indicate that NaProTechnology is a natural approach for treating infertility.

Results

The percentage of live births obtained by NaProTechnology is similar to that of ARTs.

Conclusions

An extensive search for the genetic defects causing infertility or subfertility through genetic testing can help both ARTs and NaProTechnology to achieve successful pregnancies. By discovering the underlying causes of infertility, genetic tests enable better family counseling, like the implications of transmitting risk- and disease-alleles to future generations.

Topics

NaProTECHNOLOGYInfertilityEthics/Philosophy
IVF complications NaProTECHNOLOGY implementation, assisted reproductive technology complications, ART maternal risks, multiple pregnancy IVF risk, ovarian hyperstimulation syndrome, natural procreative technology alternative, IVF neonatal outcomes, ART long-term health effects, NaPro vs IVF outcomes, reproductive technology safety comparison
PMID 33170179 33170179 DOI 10.23750/abm.v91i13-S.10525 10.23750/abm.v91i13-S.10525

Cite this article

Kiani, A. K., Paolacci, S., Scanzano, P., Michelini, S., Capodicasa, N., D'Agruma, L., Notarangelo, A., Tonini, G., Piccinelli, D., Farshid, K. R., Petralia, P., Fulcheri, E., Chiurazzi, P., Terranova, C., Plotti, F., Angioli, R., Castori, M., & Bertelli, M. (2020). Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies. *Acta bio-medica : Atenei Parmensis*, *91*(13-S), e2020018. https://doi.org/10.23750/abm.v91i13-S.10525

Keywords

Female, Genetic Testing, Humans, Infertility, Pregnancy, Reproductive Techniques, Assisted/adverse Effects, Technology

Related articles